Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_assertion type Assertion NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_head.
- NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_assertion description "[This value increased to 60%-70% after neutralization of CD46 and CD59 without an appreciable change of ADCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_provenance.
- NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_assertion evidence source_evidence_literature NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_provenance.
- NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_assertion SIO_000772 16585216 NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_provenance.
- NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_assertion wasDerivedFrom befree-20140225 NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_provenance.
- NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_assertion wasGeneratedBy ECO_0000203 NP719020.RAGRwy2q6VD5a7tc6fAc5L8Fvtf2zByi5m9RzWrUGujI0130_provenance.